AAM
Arabesque Asset Management Portfolio holdings
AUM
$296M
1-Year Est. Return
15.19%
1 Year Est. Return
-15.19%
AUM
$205M
AUM Growth
+$15.3M
(+8.1%)
Holding
144
Top Buys
| 1 | +$3.59M | |
| 2 | +$3.39M | |
| 3 | +$3.25M | |
| 4 |
Booking.com
BKNG
|
+$3.21M |
| 5 |
Amgen
AMGN
|
+$2.48M |
Top Sells
| 1 | +$2.23M | |
| 2 | +$2.12M | |
| 3 | +$2.04M | |
| 4 |
Cisco
CSCO
|
+$2.01M |
| 5 |
Eaton
ETN
|
+$1.97M |
Sector Composition
| 1 | Healthcare | 24.49% |
| 2 | Technology | 18.93% |
| 3 | Consumer Discretionary | 16.56% |
| 4 | Consumer Staples | 11.48% |
| 5 | Financials | 10.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
AutoZone
AZO
$59.5B
| $3.74M | 1.83% |
1,748
+1,583
|
|
||
2
O'Reilly Automotive
ORLY
$77.6B
| $3.59M | 1.75% |
+76,635
|
|
||
3
Linde
LIN
$192B
| $3.44M | 1.68% |
12,764
+5,787
|
|
||
4
Keurig Dr Pepper
KDP
$36.2B
| $3.42M | 1.67% |
95,334
+48,286
|
|
||
5
Colgate-Palmolive
CL
$60.4B
| $3.25M | 1.59% |
+46,268
|
|
||
|
6
Booking.com
BKNG
$162B
| $3.21M | 1.57% |
+1,956
|
|
||
7
Rogers Corp
ROG
$1.49B
| $3.18M | 1.55% |
13,142
|
|
||
8
Fortinet
FTNT
$67.1B
| $3.14M | 1.53% |
63,905
-2,108
|
|
||
9
CSX Corp
CSX
$66.7B
| $2.99M | 1.46% |
112,204
+45,362
|
|
||
10
Bristol-Myers Squibb
BMY
$93.7B
| $2.95M | 1.44% |
41,465
+12,194
|
|
||
11
Regeneron Pharmaceuticals
REGN
$67.5B
| $2.62M | 1.28% |
3,809
+474
|
|
||
12
Eli Lilly
LLY
$802B
| $2.56M | 1.25% |
7,932
-901
|
|
||
|
13
Amgen
AMGN
$160B
| $2.48M | 1.21% |
+11,009
|
|
||
14
Danaher
DHR
$151B
| $2.45M | 1.19% |
10,697
+416
|
|
||
15
Costco
COST
$411B
| $2.45M | 1.19% |
5,183
+54
|
|
||
16
Vertex Pharmaceuticals
VRTX
$109B
| $2.45M | 1.19% |
+8,453
|
|
||
17
Merck
MRK
$206B
| $2.37M | 1.16% |
27,521
+1,151
|
|
||
18
UnitedHealth
UNH
$302B
| $2.36M | 1.15% |
4,667
+339
|
|
||
19
McKesson
MCK
$102B
| $2.35M | 1.14% |
6,902
+5,608
|
|
||
20
Deckers Outdoor
DECK
$11.8B
| $2.34M | 1.14% |
44,958
-3,978
|
|
||
21
Dollar General
DG
$21.8B
| $2.33M | 1.14% |
+9,707
|
|
||
22
Humana
HUM
$33.7B
| $2.33M | 1.13% |
+4,793
|
|
||
23
Abbott
ABT
$215B
| $2.31M | 1.13% |
23,836
+5,465
|
|
||
24
Pfizer
PFE
$140B
| $2.29M | 1.12% |
52,403
+7,161
|
|
||
25
Johnson & Johnson
JNJ
$449B
| $2.29M | 1.12% |
14,030
+356
|
|